Clinical Trials
32
Trial Phases
3 Phases
Drug Approvals
5
Drug Approvals
Garenoxacin Mesilate Tablets
- Product Name
- 甲磺酸加诺沙星片
- Approval Number
- H20190043
- Approval Date
- Jul 12, 2019
Clinical Trials
Distribution across different clinical trial phases (22 trials with phase data)• Click on a phase to view related trials
Efficacy and Safety of FF-31501 in Meniscus Tear Patients
- Conditions
- Meniscus Injury
- First Posted Date
- 2023-03-21
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- FUJIFILM Toyama Chemical Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT05777967
- Locations
- 🇯🇵
Medical corporation keimeikai Juko Osu hospital, Aichi, Japan
🇯🇵Wakamatsu Hospital of the University of OccupationalOC and Environmental Health, Fukuoka, Japan
🇯🇵Mie Prefectural General Medical Center, Mie, Japan
Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD
- First Posted Date
- 2019-12-09
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- FUJIFILM Toyama Chemical Co., Ltd.
- Target Recruit Count
- 221
- Registration Number
- NCT04191486
- Locations
- 🇨🇿
FNUSA - Mezinarodni centrum klinickeho vyzkumu, Brno, Czechia
🇨🇿FNHK - Neurologicka klinika, Hradec Králové, Czechia
🇨🇿A-shine, s.r.o., Plzen, Czechia
PK Study of T-817 in Subjects With Hepatic Impairment
- First Posted Date
- 2016-02-26
- Last Posted Date
- 2017-11-24
- Lead Sponsor
- FUJIFILM Toyama Chemical Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT02693197
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸Orlando Clinical Research Center, Orlando, Florida, United States
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
- Conditions
- Alzheimer's Disease
- Interventions
- Drug: T-817MA-LDrug: PlaceboDrug: T-817MA-H
- First Posted Date
- 2014-03-06
- Last Posted Date
- 2019-02-26
- Lead Sponsor
- FUJIFILM Toyama Chemical Co., Ltd.
- Target Recruit Count
- 482
- Registration Number
- NCT02079909
- Locations
- 🇺🇸
Banner Alzheimer's Institute, Phoenix, Arizona, United States
🇺🇸Banner Sun Health Research Institute, Sun City, Arizona, United States
🇺🇸University of Arizona Health Sciences Center, Tucson, Arizona, United States
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2013-11-05
- Lead Sponsor
- FUJIFILM Toyama Chemical Co., Ltd.
- Target Recruit Count
- 373
- Registration Number
- NCT00663936
- Locations
- 🇺🇸
Banner Alzheimer's Institute, Phoenix, Arizona, United States
🇺🇸Northwest NeuroSpecialists, Tucson, Arizona, United States
🇺🇸Collaborative Neuroscience Network, Inc., Garden Grove, California, United States